Skip to main content
Transchem Limited. logo

Transchem Limited. — Investor Relations & Filings

Ticker · 500422 ISIN · INE019B01010 LEI · 3358002KFTC2CS9VDY51 BSE.NS Agriculture, forestry and fishing
Open in API
Filings indexed 360 across all filing types
Latest filing 2025-01-21 Regulatory Filings
Country IN India
Listing BSE.NS 500422

About Transchem Limited.

https://www.transchem.net/

Transchem Limited is a diversified enterprise primarily engaged in the cultivation, processing, and export of white button mushrooms. Operating through a specialized Export Oriented Unit, the company utilizes advanced technology for large-scale mushroom production, including climate-controlled growing rooms and automated processing lines. Its product portfolio features high-quality processed mushrooms available in various formats such as canned and frozen for international markets. In addition to its agribusiness operations, the company maintains a presence in the pharmaceutical sector, focusing on the manufacturing of bulk drugs and the trading of various chemical intermediates. The organization emphasizes quality control and adherence to international food safety standards to serve its global clientele.

Recent filings

Filing Released Lang Actions
Please refer the attached intimation.
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialisation activities for the quarter ended December 31, 2024. It is addressed to the stock exchange's corporate relations department and includes a confirmation from the registrar and share transfer agent. The document is short (2914 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of a report publication but a regulatory filing confirming compliance with securities regulations. Therefore, it fits best under Regulatory Filings (RNS).
2025-01-21 English
Please refer to the attachment enclosed.
Regulatory Filings
2025-01-07 English
Please refer the attached intimation.
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to a stock exchange (BSE Limited) informing about a change in the name of the company's Registrar and Share Transfer Agent. It is an announcement of a corporate administrative update rather than a financial report or detailed filing. The document length is only 920 characters, indicating it is a brief notice. There is no financial data, no mention of annual or quarterly results, no voting results, no legal proceedings, or other report types. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-03 English
Please refer the attached Intimation.
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to the stock exchange (BSE Limited) regarding the stoppage of transfer of certain share certificates due to loss and request for duplicate certificates. It references compliance with SEBI regulations and circulars related to share transfer and shareholder communication. The content is a regulatory notification about share certificate status and transfer restrictions, not a financial report, earnings release, or management discussion. It does not contain financial data, audit information, or meeting materials. The document is a regulatory announcement related to share transfer procedures and compliance, fitting best under Regulatory Filings (RNS). The document length is short (1887 characters), and it is not announcing a report publication but providing a compliance update.
2024-12-27 English
Please refer the attached Intimation.
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchange about the closure of the trading window for insiders due to upcoming unaudited financial results for the quarter and nine months ended December 31, 2024. It references the SEBI regulations on insider trading and mentions that the date of the board meeting for declaring the results will be intimated separately. The document does not contain any financial data or results itself, nor does it provide detailed financial analysis. It is essentially an announcement related to compliance and trading restrictions ahead of a financial report. Given the short length (1384 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS) rather than an Interim Report (IR) or Earnings Release (ER).
2024-12-27 English
Please find enclosed herewith the information received from M/s. Link Intime India Private Limited, the Registrar and Transfer Agent of the Company, on December 04, 2024 that they have ....
Regulatory Filings
2024-12-04 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.